SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9404706
Source:
http://linkedlifedata.com/resource/pubmed/id/9404706
Search
Subject
(
80
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021270
,
umls-concept:C0023449
,
umls-concept:C0087111
,
umls-concept:C1274040
,
umls-concept:C1511716
,
umls-concept:C1513822
,
umls-concept:C1880171
pubmed:issue
12
pubmed:dateCreated
1998-1-2
pubmed:abstractText
Infants with acute lymphoblastic leukemia (ALL) have a very poor prognosis. Since 1985, we have intensified therapy for infants with ALL by including a month of high dose multiagent chemotherapy after remission induction.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA 06516
,
http://linkedlifedata.com/resource/pubmed/grant/CA 68484
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9404706-9731916
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/6-Mercaptopurine
,
http://linkedlifedata.com/resource/pubmed/chemical/Asparaginase
,
http://linkedlifedata.com/resource/pubmed/chemical/Core Binding Factor Alpha 2 Subunit
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/MLL protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloid-Lymphoid Leukemia Protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion
,
http://linkedlifedata.com/resource/pubmed/chemical/TEL-AML1 fusion protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed-author:DonnellyM JMJ
,
pubmed-author:GelberR DRD
,
pubmed-author:GillilandD GDG
,
pubmed-author:McLeanT WTW
,
pubmed-author:SallanS ESE
,
pubmed-author:SilvermanL BLB
,
pubmed-author:TarbellN JNJ
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2285-95
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9404706-6-Mercaptopurine
,
pubmed-meshheading:9404706-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:9404706-Asparaginase
,
pubmed-meshheading:9404706-Core Binding Factor Alpha 2 Subunit
,
pubmed-meshheading:9404706-Cytarabine
,
pubmed-meshheading:9404706-DNA, Neoplasm
,
pubmed-meshheading:9404706-DNA-Binding Proteins
,
pubmed-meshheading:9404706-Disease-Free Survival
,
pubmed-meshheading:9404706-Female
,
pubmed-meshheading:9404706-Humans
,
pubmed-meshheading:9404706-Infant
,
pubmed-meshheading:9404706-Infant, Newborn
,
pubmed-meshheading:9404706-Male
,
pubmed-meshheading:9404706-Methotrexate
,
pubmed-meshheading:9404706-Myeloid-Lymphoid Leukemia Protein
,
pubmed-meshheading:9404706-Neoplasm Proteins
,
pubmed-meshheading:9404706-Oncogene Proteins, Fusion
,
pubmed-meshheading:9404706-Precursor Cell Lymphoblastic Leukemia-Lymphoma
,
pubmed-meshheading:9404706-Prognosis
,
pubmed-meshheading:9404706-Proto-Oncogenes
,
pubmed-meshheading:9404706-Remission Induction
,
pubmed-meshheading:9404706-Survival Rate
,
pubmed-meshheading:9404706-Transcription Factors
,
pubmed-meshheading:9404706-Treatment Outcome
,
pubmed-meshheading:9404706-Vincristine
pubmed:year
1997
pubmed:articleTitle
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
pubmed:affiliation
Children's Hospital, the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Multicenter Study